Women need daily doses of the antiviral medication Truvada to prevent HIV infection while men only need two doses per week due to the way the drug accumulates in different body tissues, according…
Source: HIV/AIDS news from Medical News Today
Uncategorized
Researchers unravel pathways of potent antibodies that fight HIV infection
Finding represents step toward effective HIV vaccine design.One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it…
Source: HIV/AIDS news from Medical News Today
New TSRI study shows HIV structure in unprecedented detail
A new study from scientists at The Scripps Research Institute (TSRI) describes the high-resolution structure of the HIV protein responsible for recognition and infection of host cells.
Source: HIV/AIDS news from Medical News Today
How to prevent 10 million deaths a year
Strategic investments to discover and develop new health tools, together with innovations in effectively delivering today’s health tools and services, could avert 10 million deaths a year within…
Source: HIV/AIDS news from Medical News Today
Study shows high-risk sex more likely for young men than women, even among educated urban populations
A new study of the sexual habits of nearly 85,000 young people suggests that males are at least ten times more likely to engage in high-risk sexual behaviour than their female counterparts.
Source: HIV/AIDS news from Medical News Today
HIV in Rhode Island: Newly diagnosed men often 'hooked up' online
More than 60 percent of Rhode Island men who have sex with men (MSM) diagnosed with HIV in 2013 reported meeting sexual partners online in the preceding year, according to a study published in the…
Source: HIV/AIDS news from Medical News Today
Non-integrating viral vector delivers chemotherapy-sensitizing gene to pancreatic cancer cells
A novel HIV-based lentiviral vector can introduce a gene to pancreatic tumor cells that makes them more sensitive to the chemotherapeutic drug gemcitabine, without integrating into cellular DNA.
Source: HIV/AIDS news from Medical News Today
Antidepressant may improve cognitive symptoms in people with HIV
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in…
Source: HIV/AIDS news from Medical News Today
Maraviroc-containing regimens safe, tolerable when taken for HIV prevention
Maraviroc, an oral drug used to treat HIV infection, is safe and well-tolerated when taken daily as pre-exposure prophylaxis (PrEP) to prevent HIV infection by HIV-uninfected men who have sex with…
Source: HIV/AIDS news from Medical News Today
Client-centered care coordination attains high uptake for pre-exposure prophylaxis for prevention of HIV infection among US BMSM
Investigators from the HIV Prevention Trials Network (HPTN) have announced key results from the HPTN 073 Study at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston…
Source: HIV/AIDS news from Medical News Today